LeMaitre AnastoClip GC Instructions D'utilisation page 6

2. The secondary packaging of cleaned, decontaminated AnastoClip explants should be labeled with
an ISO 7000-0659 Biohazard symbol. Outer packaging should also be labelled with "Exempt human
specimen" printed on a label with dimensions at least 10 x 10 cm.
3. Shipping paper for the outer shipping container is not required.
4. Packages prepared in the above manner may be shipped to:
Notices: Limited Product Warranty; Limitation Of Remedies
LeMaitre Vascular, Inc. warrants that reasonable care has been used in the manufacture of this device
and that this device is suitable for the indication(s) expressly specifi ed in these instructions for use.
Except as explicitly provided herein, LEMAITRE VASCULAR (AS USED IN THIS SECTION, SUCH TERM
INCLUDES LEMAITRE VASCULAR, INC., ITS AFFILIATES, AND THEIR RESPECTIVE EMPLOYEES, OFFICERS,
DIRECTORS, MANAGERS, AND AGENTS) MAKES NO EXPRESS OR IMPLIED WARRANTIES WITH RESPECT
TO THIS DEVICE, WHETHER ARISING BY OPERATION OF LAW OR OTHERWISE (INCLUDING, WITHOUT
LIMITATION, ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE)
AND HEREBY DISCLAIMS THE SAME. This limited warranty does not apply to the extent of any abuse or
misuse of, or failure to properly store, this device by the purchaser or any third party. The sole remedy
for a breach of this limited warranty shall be replacement of, or refund of the purchase price for, this
device (at LeMaitre Vascular's sole option) following the purchaser's return of the device to LeMaitre
Vascular. This warranty shall terminate on the expiration date for this device.
IN NO EVENT SHALL LEMAITRE VASCULAR BE LIABLE FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL,
SPECIAL, PUNITIVE, OR EXEMPLARY DAMAGES. IN NO EVENT WILL THE AGGREGATE LIABILITY OF
LEMAITRE VASCULAR WITH RESPECT TO THIS DEVICE, HOWEVER ARISING, UNDER ANY THEORY OF
LIABILITY, WHETHER IN CONTRACT, TORT, STRICT LIABILITY, OR OTHERWISE, EXCEED ONE THOUSAND
DOLLARS (US$1,000), REGARDLESS OF WHETHER LEMAITRE VASCULAR HAS BEEN ADVISED OF THE
POSSIBILITY OF SUCH LOSS, AND NOTWITHSTANDING THE FAILURE OF THE ESSENTIAL PURPOSE OF ANY
REMEDY. THESE LIMITATIONS APPLY TO ANY THIRD-PARTY CLAIMS.
A revision or issue date for these instructions is included on the back page of these Instructions for Use
for the user's information. If twenty-four (24) months has elapsed between this date and product use,
the user should contact LeMaitre Vascular to see if additional product information is available.
LeMaitre Vascular
63 Second Avenue
Burlington, MA 01803
6